Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-057705
Filing Date
2026-05-15
Accepted
2026-05-15 16:05:54
Documents
64
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0290433-10q_china.htm   iXBRL 10-Q 482881
2 CERTIFICATION ea029043301ex31-1.htm EX-31.1 9948
3 CERTIFICATION ea029043301ex31-2.htm EX-31.2 9862
4 CERTIFICATION ea029043301ex32-1.htm EX-32.1 5375
  Complete submission text file 0001213900-26-057705.txt   4112384

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20260331.xsd EX-101.SCH 37811
6 XBRL CALCULATION FILE cphi-20260331_cal.xml EX-101.CAL 42576
7 XBRL DEFINITION FILE cphi-20260331_def.xml EX-101.DEF 191952
8 XBRL LABEL FILE cphi-20260331_lab.xml EX-101.LAB 346828
9 XBRL PRESENTATION FILE cphi-20260331_pre.xml EX-101.PRE 203925
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0290433-10q_china_htm.xml XML 339902
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 26987093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)